INTRA-CELLULAR THERAPI

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

14 Dec 2023 08:45:34 By NetDania Notify

Intra-Cellular Therapies Highlights Data Presentations at the American College of Neuropsychopharmacology Annual Meeting

05 Dec 2023 07:00:07 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 6th Annual Evercore ISI HealthCONx Conference

15 Nov 2023 07:00:49 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance

02 Nov 2023 06:30:02 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

31 Oct 2023 07:00:16 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2023 Financial Results Conference Call and Webcast

26 Oct 2023 07:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

20 Sep 2023 07:00:46 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Presentations at Psych Congress 2023 Including Positive Results from Study 403 in Mixed Features

11 Sep 2023 07:00:14 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

05 Sep 2023 07:00:48 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference

04 Aug 2023 07:00:39 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance

03 Aug 2023 06:30:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2023 Financial Results Conference Call and Webcast

28 Jul 2023 07:00:54 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

05 Jun 2023 07:00:23 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces CAPLYTA Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

31 May 2023 07:00:37 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update

04 May 2023 06:30:56 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences

02 May 2023 07:00:39 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2023 Financial Results Conference Call and Webcast

26 Apr 2023 07:00:43 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 22nd Annual Needham Virtual Healthcare Conference

11 Apr 2023 07:00:35 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features

28 Mar 2023 06:00:12 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

01 Mar 2023 06:30:35 By Nasdaq GlobeNewswire